Doha, Qatar: In a new medical achievement, the Heart Hospital at Hamad Medical Corporation has begun using the advanced FARAVIEW™ System to treat atrial fibrillation, becoming the first medical institution in the Middle East and the first outside the United States and Europe to adopt this advanced technology.
Atrial fibrillation (AF) is one of the most common and serious types of irregular, rapid heart rhythms. It can lead to severe complications such as stroke and heart failure.
Developed by Boston Scientific to treat atrial fibrillation (AF), the FARAVIEW™ System provides physicians with unprecedented, detailed visualization of heart tissue, allowing them to accurately identify the areas responsible for irregular heart rhythms. This enhances the safety of the procedure and shortens its duration, as the system precisely targets abnormal tissue while sparing the surrounding healthy structures.
The introduction of this technology aligns with HMC’s ongoing efforts to enhance the treatment tools available to its clinicians. It also reflects the Organization’s readiness, both in staff and infrastructure, to embrace the latest medical innovations, ensuring safer procedures, faster recovery, and better long-term outcomes for patients.
This achievement represents a major milestone in the field of cardiac electrophysiology and underscores HMC’s steadfast commitment to its strategy of adopting the latest diagnostic and therapeutic technologies, while ensuring that all members of the Qatari community have access to world-class healthcare.
